|
CCBL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.325840E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.675600E-02 |
| Normal-vs-Stage2 |
9.873600E-01 |
| Normal-vs-Stage3 |
1.579240E-01 |
| Normal-vs-Stage4 |
6.647000E-01 |
| Stage1-vs-Stage2 |
2.681800E-01 |
| Stage1-vs-Stage3 |
9.573800E-01 |
| Stage1-vs-Stage4 |
2.179400E-01 |
| Stage2-vs-Stage3 |
3.169600E-01 |
| Stage2-vs-Stage4 |
7.478400E-01 |
| Stage3-vs-Stage4 |
3.209000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.535170E-01 |
| Normal-vs-AfricanAmerican |
1.438240E-02 |
| Normal-vs-Asian |
5.165000E-01 |
| Caucasian-vs-AfricanAmerican |
1.474450E-01 |
| Caucasian-vs-Asian |
6.577400E-01 |
| AfricanAmerican-vs-Asian |
7.359600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.213640E-01 |
| Normal-vs-Female |
1.835010E-01 |
| Male-vs-Female |
5.439200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.749800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.018200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.238800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.828800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.506600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.533640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.634000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.813800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.311000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.484600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.812600E-01 |
| Classical-VS-Follicular |
5.188600E-04 |
| Classical-VS-Other |
5.511400E-01 |
| Classical-VS-Normal |
1.851600E-02 |
| Tall-VS-Follicular |
5.481800E-02 |
| Tall-VS-Other |
5.803400E-01 |
| Tall-VS-Normal |
1.436770E-01 |
| Follicular-VS-Other |
5.844600E-01 |
| Follicular-VS-Normal |
4.256600E-01 |
| Other-VS-Normal |
7.871200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.179600E-01 |
| Normal-vs-N1 |
8.282400E-01 |
| N0-vs-N1 |
7.604800E-01 |
|
|
